Hugely promising cancer drug dostarlimab is one step closer to being widely available, after the Food and Drug Administration granted it Breakthrough Therapy Designation status that, if successful, …
Despite being positive about DNA-based vaccine production in general, the study did identify areas in need of better manufacturing technologies.
ChristianaCare’s Gene Editing Institute’s CRISPR in a Box™ teaching toolkit has been named the #2 innovation on The Scientist’s Top 10 Innovations list for 2024.…
This timeline details the key discoveries leading to the development of CRISPR-Cas9 gene editing. It highlights the contributions of numerous scientists, from the initial observation of…
The company is launching a Phase Ib study that will test its first gene therapy in patients with locally advanced rectal cancer.
GPT-4 mimics cultural traits impressively, but its prompt-driven outputs reveal shallow understanding.
Scientists plan to borrow nature’s tools to develop and study fungal compounds further, which could lead to the development of new drugs.
High-resolution imaging of bone resorption-formation sequences reveals insights into mechanobiology of human bone remodeling.
Researchers reveal new insights on the growth of craniopharyngioma and identified a potential therapeutic treatment.
LNPs are mixture of nucleic acids, lipids, and peptides. Team had to optimize quantification methods to pick out the peptides against all those other signals.”
